- Home
- MREO vs EDD Comparison
MREO vs EDD Comparison
Compare MREO & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- EDD
- Stock Information
- Founded
- MREO 2015
- EDD 2007
- Country
- MREO United Kingdom
- EDD United States
- Employees
- MREO N/A
- EDD N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- EDD Finance Companies
- Sector
- MREO Health Care
- EDD Finance
- Exchange
- MREO Nasdaq
- EDD Nasdaq
- Market Cap
- MREO 369.2M
- EDD 307.8M
- IPO Year
- MREO N/A
- EDD N/A
- Fundamental
- Price
- MREO $2.30
- EDD $4.64
- Analyst Decision
- MREO Strong Buy
- EDD
- Analyst Count
- MREO 7
- EDD 0
- Target Price
- MREO $7.71
- EDD N/A
- AVG Volume (30 Days)
- MREO 1.7M
- EDD 254.3K
- Earning Date
- MREO 05-14-2025
- EDD 01-01-0001
- Dividend Yield
- MREO N/A
- EDD 7.52%
- EPS Growth
- MREO N/A
- EDD N/A
- EPS
- MREO N/A
- EDD N/A
- Revenue
- MREO N/A
- EDD N/A
- Revenue This Year
- MREO N/A
- EDD N/A
- Revenue Next Year
- MREO $61.92
- EDD N/A
- P/E Ratio
- MREO N/A
- EDD N/A
- Revenue Growth
- MREO N/A
- EDD N/A
- 52 Week Low
- MREO $1.58
- EDD $4.22
- 52 Week High
- MREO $5.02
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- MREO 52.99
- EDD 49.37
- Support Level
- MREO $1.58
- EDD $4.35
- Resistance Level
- MREO $2.37
- EDD $4.67
- Average True Range (ATR)
- MREO 0.21
- EDD 0.13
- MACD
- MREO 0.04
- EDD 0.01
- Stochastic Oscillator
- MREO 91.19
- EDD 72.00
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.